Librede logo — Enhancing lives with sustainable biotechnologies for therape...

Librede

Enhancing lives with sustainable biotechnologies for therapeutic innovation.

Founded 2009 Grant Total: $1.64M Biotechnology, Health and Wellness +1

General Information

Company Name Librede
Founded Year 2009
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Librede. To contact Librede, visit librede.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Librede compare?

A PDF of Librede and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Librede soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Librede

Librede is a biotechnology and pharmaceutical startup committed to enhancing lives through sustainable technological innovations. Established in 2009, the company's slogan "Enhancing lives with sustainable biotechnologies for therapeutic innovation" reflects its dedication to improving the quality of life. Librede specializes in developing platform technologies that facilitate the creation of novel therapeutics by leveraging biology to build devices and manufacture molecules. One of their notable achievements is pioneering the world's first biosynthetic production platform aimed at the endocannabinoid system. Their last investment amounted to $1.49 million in the form of a grant investment on 13 February 2018, received from the National Center for Complementary and Integrative Health (NCCIH). This funding demonstrates confidence in Librede's innovative approach and potential impact in the biotechnology and pharmaceutical industries.

Business keywords: therapeutic innovation, sustainable technology, platform technologies, novel therapeutics, biology-based devices, molecule manufacturing, biosynthetic production, endocannabinoid system, sustainable innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $1.49M 1
National Center for Complementary and Integrative Health
13 Feb 2018
Grant $150.00K 1
National Science Foundation
05 Jun 2012

Librede Alternatives & Competitors

View All Alternatives
Librede vs

Modulating immunity with the small—yet, mighty—nanobody

7 employees
Biotechnology, Health and Wellness
Librede vs

Unravelling complex biology with optogenetics, chemistry and computation for small molecule discover...

Seed
18 employees
Biopharma, Biotechnology
Librede vs

Pioneering the expanded human proteome to reveal a universe of new medicines.

51 employees
Biotechnology, Pharmaceutical

FAQ About Librede

Enhancing lives with sustainable biotechnologies for therapeutic innovation.
Librede was founded in 2009.
Librede operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on therapeutic innovation, sustainable technology, platform technologies and novel therapeutics.
Librede has completed 2 funding rounds, raising a total of $1.64M. The latest funding stage is Grant.
Top alternatives and competitors to Librede include Cerberus Therapeutics, Integrated Biosciences, Inc., ProFound Therapeutics, Generate:Biomedicines, CAMP4 Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Librede and Cerberus Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Librede, https://bouncewatch.com/company/librede, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes